Rational Identification of Novel Antibody‐Drug Conjugate with High Bystander Killing Effect against Heterogeneous Tumors
Abstract
Research context
OpenAlex topics: HER2/EGFR in Cancer Research · Protein Degradation and Inhibitors · Computational Drug Discovery Methods
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Hangzhou Institute of Innovative Medicine, Institute of Drug Discovery and Design, College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 P. R. China
Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University Hangzhou 310018 P. R. China
The Department of Pharmacy Zhejiang Cancer Hospital Hangzhou 310022 P. R. China
Department of Hepatobiliary and Pancreatic Surgery the First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou 310002 P. R. China
Cancer Center Zhejiang University Hangzhou 310058 P. R. China
Department of Pharmacy Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou 310009 P. R. China
Funding
Natural Science Foundation of Zhejiang Province · National Natural Science Foundation of China